Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
São Paulo med. j ; 124(5): 298-303, Sept. 2006.
Article in English | LILACS, BVSAM | ID: lil-440168

ABSTRACT

Medical progress has reduced the mortality from infectious diseases in most countries, but allergic diseases have become more prevalent worldwide over the same period, especially in industrialized countries. This has prompted speculation that modern lifestyles have altered the relationship between heredity and environment so as to promote development of an atopic phenotype when exposure to infection decreases. A healthy uterine microenvironment is known to favor Th2 lymphocyte development. However, some evidence suggests that persistence of the Th2 pattern of immunity directs the developing organism's immune response towards a long-lasting atopic phenotype. Even though the outcome also depends on other factors (such as infection, functional state of the intestinal microflora, and exposure to environmental allergens at times critical to development), it seems that the immune system during the perinatal period is responsive to interventions that are no longer effective in adulthood. We have reviewed the literature accessible through Medline to identify recent advances in the prevention of allergic disease through interventions in the fetal-maternal relationship. Diet seems to have a significant impact on the immunological profile of the pregnant uterus, as well as on the postnatal development of allergic disease in the offspring, as suggested by the effects of probiotic bacteria and by manipulations of the dietary content of polyunsaturated fatty acids and antioxidants. This highlights the need for further studies, in order to define the best intervention methods, the most appropriate time interval and the individuals who will most likely benefit from them.


Progressos médicos reduziram a mortalidade por doenças infecciosas em muitos países, mas doenças alérgicas tornaram-se mais prevalentes no mundo inteiro, no mesmo período, especialmente nos países industrializados, levando alguns a postular que a vida moderna influencia as relações entre hereditariedade e meio ambiente de forma a favorecer o desenvolvimento de atopia quando a exposição a agentes infecciosos diminui. O micro-ambiente fisiológico do útero gravídico favorece o desenvolvimento de linfócitos Th2. Contudo, a evidência sugere que um padrão persistente de imunidade Th2 direciona a resposta imune do organismo em desenvolvimento para um fenótipo atópico duradouro. Embora o resultado dependa de outros fatores, incluindo infecções, o estado funcional da microflora intestinal, e a exposição a alergenos ambientais em momentos críticos do desenvolvimento, o sistema imune no período perinatal permanece suscetível a intervenções que não têm efeito no adulto. Fizemos uma revisão da literatura acessível através da Medline para identificar avanços recentes na prevenção de doenças alérgicas por meio de intervenção na relação materno-fetal. A dieta parece ter um impacto significativo sobre o perfil imunológico do útero gravídico, assim como sobre o desenvolvimento pós-natal de doença alérgica, como sugerido pelos efeitos de bactérias probióticas e pela manipulação do conteúdo de ácidos graxos poli-insaturados e de antioxidantes na dieta. Isso reforça a necessidade de estudos mais amplos para determinar o melhor tipo de intervenção, o momento mais adequado e os indivíduos que mais serão beneficiados.


Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Infant , Diet , Hypersensitivity/prevention & control , Maternal-Fetal Exchange/immunology , Prenatal Exposure Delayed Effects/prevention & control , /immunology , Antioxidants/therapeutic use , Asthma/prevention & control , Cytokines , Dermatitis, Atopic/prevention & control , Dietary Fats, Unsaturated/therapeutic use , Hypersensitivity/immunology , Immunoglobulin E/immunology , Prenatal Exposure Delayed Effects/immunology , Probiotics/therapeutic use , Umbilical Cord , Uterus/immunology
2.
Sao Paulo Med J ; 124(5): 298-303, 2006 Sep 07.
Article in English | MEDLINE | ID: mdl-17262164

ABSTRACT

Medical progress has reduced the mortality from infectious diseases in most countries, but allergic diseases have become more prevalent worldwide over the same period, especially in industrialized countries. This has prompted speculation that modern lifestyles have altered the relationship between heredity and environment so as to promote development of an atopic phenotype when exposure to infection decreases. A healthy uterine microenvironment is known to favor Th2 lymphocyte development. However, some evidence suggests that persistence of the Th2 pattern of immunity directs the developing organism's immune response towards a long-lasting atopic phenotype. Even though the outcome also depends on other factors (such as infection, functional state of the intestinal microflora, and exposure to environmental allergens at times critical to development), it seems that the immune system during the perinatal period is responsive to interventions that are no longer effective in adulthood. We have reviewed the literature accessible through Medline to identify recent advances in the prevention of allergic disease through interventions in the fetal-maternal relationship. Diet seems to have a significant impact on the immunological profile of the pregnant uterus, as well as on the postnatal development of allergic disease in the offspring, as suggested by the effects of probiotic bacteria and by manipulations of the dietary content of polyunsaturated fatty acids and antioxidants. This highlights the need for further studies, in order to define the best intervention methods, the most appropriate time interval and the individuals who will most likely benefit from them.


Subject(s)
Diet , Hypersensitivity/prevention & control , Maternal-Fetal Exchange/immunology , Prenatal Exposure Delayed Effects/prevention & control , Th2 Cells/immunology , Uterus/immunology , Antioxidants/therapeutic use , Asthma/prevention & control , Cytokines , Dermatitis, Atopic/prevention & control , Dietary Fats, Unsaturated/therapeutic use , Female , Humans , Hypersensitivity/immunology , Immunoglobulin E/immunology , Infant , Infant, Newborn , Pregnancy , Prenatal Exposure Delayed Effects/immunology , Probiotics/therapeutic use , Umbilical Cord
3.
Br J Pharmacol ; 135(5): 1315-23, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11877341

ABSTRACT

1. We evaluated whether immunization affects bone-marrow responses to indomethacin, because allergenic sensitization and challenge upregulate responses to haemopoietic cytokines (including IL-5-driven eosinopoiesis) in murine bone-marrow, while indomethacin upregulates haemopoiesis and protects bone-marrow from radiation damage. 2. Progenitor (semi-solid) and/or precursor (liquid) cultures were established from bone-marrow of: (a) normal mice; (b) ovalbumin-sensitized mice, with or without intranasal challenge. Cultures were established with GM-CSF (2 ng ml(-1)) or IL-5 (1 ng ml(-1)), respectively, alone or associated with indomethacin (10(-7) - 10(-11) M) or aspirin (10(-7) - 10(-8) M). Total myeloid colony numbers and numbers of eosinophil-peroxidase-positive cells were determined at day 7. 3. In naïve BALB/c mice, indomethacin (10(-7) - 10(-9) M) increased GM-CSF-stimulated myeloid colony formation (P=0.003 and P=0.009, respectively). In contrast, it had no effect on bone-marrow of ovalbumin-sensitized and challenged mice. Indomethacin (10(-7) - 10(-9) M) also increased eosinophil precursor responses to IL-5 in bone-marrow of naïve (P<0.001 and P=0.002 respectively), but not sensitized-challenged mice. Aspirin (10(-7) M) had similar effects, equally abolished by sensitization. Enhancement of haemopoiesis by indomethacin required adherent cells from naïve bone-marrow. Nonadherent cells responded to IL-5 but not to indomethacin. Indomethacin was effective on bone-marrow from sham-sensitized, ovalbumin-challenged, but not from sensitized, saline-challenged mice. Plasma transfer from immune mice abolished eosinophil precursor responses to indomethacin in bone-marrow of naïve recipients. This was not prevented by previous removal of antibody from immune plasma. 4. COX inhibitors enhance haemopoiesis in naïve but not allergic mice. Responsiveness to indomethacin can be abolished either by active sensitization or by immune plasma transfer. Specific antibody is not involved.


Subject(s)
Bone Marrow Cells/metabolism , Cyclooxygenase Inhibitors/pharmacology , Hematopoiesis/drug effects , Up-Regulation , Animals , Aspirin/pharmacology , Bone Marrow Cells/immunology , Female , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Hematopoiesis/immunology , Immunization , Indomethacin/pharmacology , Interleukin-5/pharmacology , Male , Mice , Mice, Inbred BALB C
SELECTION OF CITATIONS
SEARCH DETAIL
...